Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
02/04/1993 | WO1993002093A1 Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides |
02/03/1993 | EP0525917A2 Double-stranded RNA correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles |
02/03/1993 | EP0525882A1 Quantification of nucleic acid |
02/03/1993 | EP0525821A2 Methods and structures employing non-radioactive chemically-labeled polynucleotide probes |
02/03/1993 | EP0525181A1 Novel lanthanide chelate-conjugated oligonucleotides. |
02/03/1993 | EP0525076A1 Recombinant bile salt activated lipases |
02/03/1993 | EP0524997A1 2'-o-alkyl nucleotides and polymers containing them. |
02/03/1993 | EP0524942A1 Method of synthesizing sulfurized oligonucleotide analogs |
02/03/1993 | EP0288513B1 Hybridization assay and means to be used in the assay |
02/02/1993 | US5183885 Method for chromatographic separation of synthetic phosphorothioate oligonucleotides |
02/02/1993 | US5183748 By synthesizing the complementary strand of a single-stranded DNA piece enzymatically |
02/02/1993 | CA1313359C Method of isolating and purifying nucleic acids from biological samples |
01/27/1993 | EP0524864A1 Method for immobilizing a nucleic acid fragment by passive adsorption on a solid support, solid support obtained therefrom and its utilisation |
01/27/1993 | EP0524604A2 Process for the preparations of S-(+)-2,2-dimethyl-cyclopropane carboxamid by genetically engineered microorganismes |
01/26/1993 | US5182366 Simplified method of forming identifiable sequences of amino acids |
01/21/1993 | WO1993001204A1 Method and compounds for rna synthesis |
01/21/1993 | DE4223438A1 Cyclische oligonucleotidphosphorthioate Cyclic oligonucleotidphosphorthioate |
01/20/1993 | EP0523978A1 Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides |
01/20/1993 | EP0523557A1 Immobilisation of nucleic acids |
01/20/1993 | EP0523140A1 Reagents and methods for modulating gene expression through rna mimicry |
01/20/1993 | CN1068035A Abrogation of uiral resistance to nucleoside analogues by double-stranded rnas |
01/20/1993 | CN1068017A Yogourt |
01/19/1993 | US5180820 Nucleic acid sequence code |
01/19/1993 | US5180668 Hirudin derivative |
01/17/1993 | CA2073989A1 Immobilization of nucleic acids |
01/12/1993 | US5179200 Nucleosides |
01/12/1993 | US5178859 Monoclonal antibodies for binding an antigen of Borrelia and epitopes |
01/12/1993 | CA1312567C Yeast strains with reduced intracellular atp levels |
01/07/1993 | WO1993000447A1 Amplification of target nucleic acids using gap filling ligase chain reaction |
01/07/1993 | WO1993000352A1 Sequence-specific binding polymers for duplex nucleic acids |
01/07/1993 | WO1992019770A3 Process for the in vitro diagnosis of chromosomal anomalies correlated with cmt1a disease |
01/07/1993 | EP0521586A1 FSH and other recombinant hormones |
01/07/1993 | EP0506830A4 Uncharged morpholino-based polymers having phosphorous-containing chiral intersubunit linkages |
01/07/1993 | EP0484440A4 Efficient directional genetic cloning system |
01/07/1993 | EP0418309A4 Oligonucleotide analogs containing sulfur |
01/05/1993 | US5177198 Process for preparing oligoribonucleoside and oligodeoxyribonucleoside boranophosphates |
01/05/1993 | US5177196 Used for diagnostic and chemotherapeutic purposes |
01/05/1993 | US5176996 Method for making synthetic oligonucleotides which bind specifically to target sites on duplex DNA molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use |
12/30/1992 | EP0520014A1 Multichromophore fluorescent probes |
12/30/1992 | EP0395672B1 Antiviral application of alpha oligonucleotides |
12/29/1992 | WO1993001286A2 Localized oligonucleotide therapy |
12/29/1992 | US5175273 Pyridinone or pyrimidinone nucleoside bases containing fused aromatic polycyclic rings |
12/29/1992 | US5175209 Porous wafer for segmented synthesis of biopolymers |
12/29/1992 | US5175082 Method of characterizing genomic dna |
12/29/1992 | US5174962 Apparatus for determining DNA sequences by mass spectrometry |
12/23/1992 | WO1992022671A1 Polynucleotide determination with selectable cleavage sites |
12/23/1992 | WO1992022303A1 Selective inhibition of leukemic cell proliferation by bcr-abl antisense oligonucleotides |
12/23/1992 | EP0519463A1 Synthetic, catalytic oligonucleotides |
12/23/1992 | CA2110591A1 Polynucleotide determination with selectable cleavage sites |
12/23/1992 | CA2103377A1 Selective inhibition of leukemic cell proliferation by bcr-abl antisense oligonucleotides |
12/22/1992 | US5173294 Purified antiserum which recognizes homophilus influenzae outer membrane protein for treating diseases caused by pathogen |
12/16/1992 | EP0518443A1 Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome |
12/16/1992 | EP0518096A1 Yogurt containing living microorganisms |
12/16/1992 | EP0517859A1 Oligonucleotide therapies for modulating the effects of herpesviruses |
12/16/1992 | EP0517829A1 Improved chimeric toxins |
12/16/1992 | EP0517796A1 Oligonucleotide analogs. |
12/16/1992 | EP0517704A1 Primers and process for detecting human papillomavirus genotypes by pcr. |
12/15/1992 | CA1311428C Deoxyribonucleoside phosphoramidites in which an aliphatic amino group is attached to the sugar ring and their use for the preparation of oligonucleotides containing aliphatic amino groups, fluorescent dyes, and other detectable moieties |
12/10/1992 | WO1992021692A1 Oligo-2'-deoxynucleotides and their use as drugs with an antiviral action |
12/10/1992 | WO1992021691A1 2',5'-nucleotide analogs as antiviral agents |
12/10/1992 | WO1992021353A1 Compositions and delivery systems for transdermal administration of neutral oligomers |
12/10/1992 | WO1992014821A3 Nestin expression as an indicator of neuroepithelial tumors |
12/10/1992 | CA2110040A1 Compositions and delivery systems for transdermal administration of neutral oligomers |
12/08/1992 | WO1992022561A1 A process for synthesis of silyl alcohols |
12/08/1992 | WO1992021689A1 Silyl phosphorylating reagents and methods of using them |
12/08/1992 | US5169941 DNA sequences coding for the DR β-chain locus of the human lymphocyte antigen complex and polypeptides, diagnostic typing processes and products related thereto |
12/08/1992 | CA2107911A1 Silyl phosphorylating reagents and methods of using them |
12/08/1992 | CA2107909A1 A process for the synthesis of silyl alcohols |
12/08/1992 | CA1311201C Desazapurine-nucleoside derivatives, processes for the preparation thereof, pharmaceutical compositions containing them and the use thereof fornucleic acid sequencing and as antiviral agents |
12/07/1992 | WO1992021375A1 Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
12/06/1992 | WO1992021690A1 Purine base modified 2'-deoxyribonucleosides, use in triplex forming oligonucleotides and process for preparing the same |
12/06/1992 | CA2088787A1 Purine base modified 2'-deoxyribonucleosides, use in triplex forming oligonucleotides and process for preparing the same |
12/02/1992 | EP0516396A1 Eimeria acervulina dna probes |
12/02/1992 | EP0515569A1 Calcium channel compositions and methods |
12/02/1992 | EP0515395A1 Sapphyrins, derivatives and synthesis |
12/02/1992 | EP0450048A4 Stable mammalian cell lines that express aromatase |
12/01/1992 | US5168049 Production of streptavidin-like polypeptides |
11/30/1992 | CA2069583A1 Eimeria acervulina dna probes |
11/26/1992 | WO1992020823A1 Backbone modified oligonucleotide analogs |
11/26/1992 | WO1992020822A1 Backbone modified oligonucleotide analogues |
11/26/1992 | WO1992020821A1 cDNA-PHOTOFLUOR PROBE AND METHODS OF MAKING, ASSAYING AND USING SAME |
11/26/1992 | WO1992020801A1 Novel antipathogenic peptides and compositions containing same |
11/26/1992 | WO1992020703A1 The use of nucleic acid analogues in diagnostics and analytical procedures |
11/26/1992 | WO1992020702A1 Peptide nucleic acids |
11/26/1992 | WO1992020698A1 Sequence specific dna binding drugs |
11/26/1992 | WO1992020348A1 Treatment of colorectal carcinoma with antisense oligonucleotides to c-myb proto-oncogene |
11/26/1992 | DE4117186A1 Oligo-2'-desoxynukleotide und ihre verwendung als arzneimittel mit antiviraler wirksamkeit Oligo-2'-deoxynucleotides and their use as medicaments having antiviral efficacy |
11/26/1992 | CA2109829A1 Treatment of colorectal carcinoma with antisense oligonucleotides to c-myb proto-oncogene |
11/26/1992 | CA2109805A1 The use of nucleic acid analogues in diagnostics and analytical procedures |
11/26/1992 | CA2103378A1 Backbone modified oligonucleotide analogues |
11/26/1992 | CA2083272A1 Novel antipathogenic peptides and compositions containing same |
11/25/1992 | EP0514513A1 Method and means for oligonucleotide synthesis. |
11/25/1992 | EP0514488A1 Retinoid receptor compositions and methods |
11/25/1992 | EP0427745A4 Solid phase assembly and reconstruction of biopolymers |
11/24/1992 | US5166387 Method of synthesizing sulfurized oligonucleotide analogs with thiuram disulfides |
11/24/1992 | US5166330 Process for the preparation of nucleoside alkyl-aralkyl- and aryl-phosphonites and -phosphonates |
11/24/1992 | US5166315 Sequence-specific binding polymers for duplex nucleic acids |
11/24/1992 | CA1310600C Oligonucleotide functionalizing reagents and methods |
11/22/1992 | CA2103464A1 Backbone modified oligonucleotide analogs |
11/19/1992 | EP0513849A2 Zea mays plants and transgenic Zea mays plants regenerated from protoplasts or protoplast-derived cells |